Ironwood Pharma (NASDAQ: IRWD) reported Q1 EPS of ($0.38), $0.06 better than the analyst estimate of ($0.44). Revenue for the quarter came in at $14.6 million versus the consensus estimate of $8.52 million.

For earnings history and earnings-related data on Ironwood Pharma (IRWD) click here.